arinsar

  Virica Biotech is excited to welcome Dr. James Taylor, co-founder and former CEO of Precision NanoSystems, to our Board of Directors! James transformed PNI into a global leader in lipid-nanoparticle and mRNA-based genetic-medicine platforms, guiding its acquisition by Danaher and integration into Cytiva’s Life Sciences portfolio. With deep expertise in microfluidics, nanotechnology, and scaling [...]

Invest Ottawa announces Virica’s graduation from its flagship program following significant growth, increased revenue, team expansion, creating numerous jobs, and securing critical funding. As Virica transitions to the IO ScaleUp program, its aim is to expand services, enter new markets, and continue helping life-saving cell and gene therapies scale. Read Full Article: LINK HERE

  On June 24, 2024, Yasir Naqvi, Parliamentary Secretary to the Minister of Health and Member of Parliament for Ottawa Centre, on behalf of the Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), announced a $1.5 million repayable investment to support the expansion of Virica's new facility [...]

Virica has been selected as a project lead for one of NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals planned projects, which aim to address key opportunities for innovation in biopharmaceutical manufacturing. NIIMBL is a public-private partnership whose mission is to accelerate biopharmaceutical manufacturing. Virica, with support from NIIMBL members AstraZeneca and Sartorius Stedim Biotech, aims to increase [...]

Our own Ella Korets-Smith, Chief Strategy Officer and co-founder of Virica Biotech, has been featured in the Ottawa Business Journal for her impactful role in advancing breakthrough biotechnology to “democratize gene therapy.” Virica’s vision is to make gene therapies accessible and affordable. Ella shares her entrepreneurial journey building Virica from an idea to a thriving [...]